Erratum to: The effectiveness of targeting never or rarely screened women in a national cervical cancer screening program for underserved women

[1]  D. Buckman,et al.  When performance management works: A study of the National Breast and Cervical Cancer Early Detection Program , 2014, Cancer.

[2]  J. King,et al.  Predictors of Never Being Screened for Cervical Cancer by Metropolitan Area , 2014, Journal of Community Health.

[3]  E. Unger,et al.  Population-based surveillance for cervical cancer precursors in three central cancer registries, United States 2009 , 2014, Cancer Causes & Control.

[4]  C. Klabunde,et al.  Challenges in Meeting Healthy People 2020 Objectives for Cancer-Related Preventive Services, National Health Interview Survey, 2008 and 2010 , 2014, Preventing chronic disease.

[5]  Robert P Berkowitz,et al.  2012 updated consensus guidelines for the management of abnormal cervical cancer screening tests and cancer precursors. , 2013, Obstetrics and gynecology.

[6]  M. Schiffman,et al.  Human Papillomavirus Infection and the Multistage Carcinogenesis of Cervical Cancer , 2013, Cancer Epidemiology, Biomarkers & Prevention.

[7]  Han-Yang Chen,et al.  Cervical cancer screening in the United States, 1993-2010: characteristics of women who are never screened. , 2012, Journal of women's health.

[8]  V. Moyer,et al.  Screening for Cervical Cancer: U.S. Preventive Services Task Force Recommendation Statement , 2012, Annals of Internal Medicine.

[9]  M. Schiffman,et al.  American Cancer Society, American Society for Colposcopy and Cervical Pathology, and American Society for Clinical Pathology screening guidelines for the prevention and early detection of cervical cancer , 2012 .

[10]  L. Paszat,et al.  HPV testing in primary cervical screening: a systematic review and meta-analysis. , 2012, Journal of obstetrics and gynaecology Canada : JOGC = Journal d'obstetrique et gynecologie du Canada : JOGC.

[11]  H. Lawson,et al.  Assessment of Follow-Up for Low-Grade Cytological Abnormalities in the National Breast and Cervical Cancer Early Detection Program, 2000—2005 , 2009 .

[12]  S. Coughlin,et al.  Burden of cervical cancer in the United States, 1998–2003 , 2008, Cancer.

[13]  H. Lawson,et al.  Assessment of Follow-Up for Low-Grade Cytological Abnormalities in the National Breast and Cervical Cancer Early Detection Program, 2000-2005 , 2008, Journal of lower genital tract disease.

[14]  T. Wright,et al.  2006 Consensus Guidelines for the Management of Women With Abnormal Cervical Screening Tests , 2007, Journal of lower genital tract disease.

[15]  S. Coughlin,et al.  Cervical Cancer Incidence in the United States by Area of Residence, 1998–2001 , 2007, Obstetrics and gynecology.

[16]  M. Manos,et al.  Cervical cancer in women with comprehensive health care access: attributable factors in the screening process. , 2005, Journal of the National Cancer Institute.

[17]  A. Moscicki,et al.  American Cancer Society Guideline for the Early Detection of Cervical Neoplasia and Cancer , 2002, CA: a cancer journal for clinicians.

[18]  Mark Sherman,et al.  The 2001 Bethesda System: terminology for reporting results of cervical cytology. , 2002, JAMA.

[19]  R. Hiatt,et al.  Papanicolaou smear history and diagnosis of invasive cervical carcinoma among members of a large prepaid health plan , 2000, Journal of lower genital tract disease.

[20]  Thomas C Wright,et al.  The ATHENA human papillomavirus study: design, methods, and baseline results. , 2012, American journal of obstetrics and gynecology.

[21]  R. Hayes,et al.  Cancer Causes & Control , 2004, Cancer Causes & Control.

[22]  W. Callaghan,et al.  Morbidity and Mortality Weekly Report , 2002 .

[23]  Hagerstoten.  American society for colposcopy and cervical pathology. , 1999, Journal of lower genital tract disease.

[24]  B Mac Mahon,et al.  Cancer causes and control. , 1990, Cancer causes & control : CCC.